NLTX

Neoleukin Therapeutics Inc

NASDAQ

Add Alert

NLTX

Neoleukin Therapeutics Inc

NASDAQ

Add Alert

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Live Updating

Older

mick

01/01/24 3:47 PM

Post #126

https://www.otcmarkets.com/stock/NLTX

mick

12/19/23 12:54 PM

Post #125

https://www.otcmarkets.com/stock/N,TX

mick

11/05/23 1:17 PM

Post #124

https://www.otcmarkets.com/stock/NLTX

mick

11/05/23 1:17 PM

Post #123

https://www.otcmarkets.com/stock/NLTX

mick

09/24/23 3:34 PM

Post #122

https://www.otcmarkets.com/stock/NLTX

mick

08/13/23 5:22 PM

Post #121

NLTX
Neoleukin Therapeutics Inc
0.62
-0.012 (-1.90%)
Volume: 41,286
Day Range: 0.61 - 0.6399
Last Trade Time: 4:00:00 PM EDT

AJ Freely

07/21/23 8:56 AM

Post #120

$NLTX -Announce Definitive Merger Agreement with Neoleukin | 7/19/23
Combined company to have $200m in cash
To close Q4 '23
Up 6.4% Pre-Market/ Current Price $0.72

tw0122

07/18/23 6:32 AM

Post #119

Neurogene and Neoleukin Announce Definitive Merger Agreement

Source: GlobeNewswire Inc.

Neurogene Inc., a clinical-stage company founded to bring life-changing genetic medicines to patients and families affected by rare neurological diseases, and Neoleukin Therapeutics, Inc. (NASDAQ:NLTX) today announced that they have entered into a definitive

mick

07/09/23 4:06 PM

Post #118

NLTX
Neoleukin Therapeutics Inc
0.84
0.0039 (0.47%)
Volume: 41,492
Day Range: 0.815 - 0.847
Last Trade Time: 4:40:38 PM EDT

mick

06/25/23 11:34 AM

Post #117

NLTX
Neoleukin Therapeutics Inc
0.771
0.0109 (1.43%)
Volume: 103,148
Day Range: 0.750101 - 0.8106
Last Trade Time: 5:42:29 PM EDT

mick

06/25/23 11:34 AM

Post #116

NLTX
Neoleukin Therapeutics Inc
0.771
0.0109 (1.43%)
Volume: 103,148
Day Range: 0.750101 - 0.8106
Last Trade Time: 5:42:29 PM EDT

mick

05/28/23 5:15 PM

Post #115

NLTX
Neoleukin Therapeutics Inc
0.82
0.01 (1.23%)
Volume: 34,560
Day Range: 0.81 - 0.83
Last Trade Time: 4:40:59 PM EDT

mick

04/30/23 5:18 PM

Post #114

NLTX
Neoleukin Therapeutics Inc
0.8948
0.0217 (2.49%)
Volume: 196,980
Day Range: 0.8599 - 0.8944
Last Trade Time: 7:52:42 PM EDT

mick

04/15/23 11:33 AM

Post #113

Re: #112: @mick - NLTX Neoleukin Therapeutics Inc

52WK RANGE 0.38 - 1.56

Bullish

mick

04/15/23 11:32 AM

Post #112

NLTX
Neoleukin Therapeutics Inc
0.79
0.0072 (0.92%)
Volume: 161,187
Day Range: 0.7723 - 0.7943
Last Trade Time: 5:10:01 PM EDT

Bullish

mick

02/26/23 7:31 PM

Post #111

NLTX
Neoleukin Therapeutics Inc
0.5104
-0.0395 (-7.18%)
Volume: 43,495
Day Range: 0.503 - 0.537501
Last Trade Time: 4:00:00 PM EST

mick

02/21/23 5:32 PM

Post #110

NLTX
Neoleukin Therapeutics Inc
0.517
-0.01315 (-2.48%)
Volume: 102,340
Day Range: 0.501 - 0.5399
Last Trade Time: 4:08:16 PM EST

mick

02/05/23 6:03 PM

Post #109

NLTX
Neoleukin Therapeutics Inc
0.60
0.0217 (3.75%)
Volume: 160,071
Day Range: 0.5801 - 0.633179
Last Trade Time: 4:36:19 PM EST

mick

12/18/22 5:17 PM

Post #108

NLTX
Neoleukin Therapeutics Inc
0.4498
-0.0028 (-0.62%)
Volume: 4,377,094
Day Range: 0.433 - 0.50
Last Trade Time: 7:41:01 PM EST

mick

10/23/22 1:07 PM

Post #107

NLTX
Neoleukin Therapeutics Inc
0.6301
0.0601 (10.54%)
Volume: 139,333
Day Range: 0.57 - 0.643599
Bid: 0.4974
Ask: 0.761
Last Trade Time: 7:14:10 PM EDT
Total Trades: 429
NLTX Detailed Quote

mick

08/31/22 5:53 PM

Post #106

NLTX
Neoleukin Therapeutics Inc
1.03
-0.03 (-2.83%)
Volume: 113,175
Day Range: 1.00 - 1.06
Bid: 1.01
Ask: 1.08
Last Trade Time: 4:02:39 PM EDT
Total Trades: 424
NLTX Detailed Quote

mick

07/17/22 5:35 PM

Post #105

NLTX
Neoleukin Therapeutics Inc
1.08
0.04 (3.85%)
Volume: 70,878
Day Range: 1.02 - 1.10
Bid: 0.98
Ask: 1.14
Last Trade Time: 4:00:00 PM EDT
Total Trades: 544
NLTX Detailed Quote

mick

06/04/22 5:23 PM

Post #104

Neoleukin Therapeuti (NLTX)
0.9943 ? 0.079 (8.63%)
Volume: 176,727 @06/03/22 6:10:35 PM EDT
Bid Ask Day's Range
0.89 0.9899 0.9 - 0.9799
NLTX Detailed Quote

mick

05/01/22 3:36 PM

Post #103

Re: #102: @mick - Neoleukin Therapeuti (NLTX)

Neoleukin Therapeutics Announces Preclinical Data for NL-201 at American Association for Cancer Research (AACR) Annual Meeting • GlobeNewswire Inc. • 04/13/2022 02:00:00 PM
Mizuho Securities Sticks to Their Buy Rating for Neoleukin Therapeutics (NLTX) • TipRanks • 04/11/2022 02:25:10 AM

mick

05/01/22 3:36 PM

Post #102

Neoleukin Therapeuti (NLTX)
1.22 ? -0.02 (-1.61%)
Volume: 405,223 @04/29/22 4:00:48 PM EDT
Bid Ask Day's Range
1.18 1.33 1.21 - 1.36
NLTX Detailed Quote

crudeoil24 PremiumMember

04/04/22 1:48 PM

Post #101

Neoleukin Therapeutics Is Maintained at Overweight by Piper Sandler

crudeoil24 PremiumMember

04/04/22 1:32 PM

Post #100

NLTX moving up before ACCR > Neoleukin Therapeutics, Inc., "Neoleukin" (NASDAQ:NLTX), a biopharmaceutical company utilizing sophisticated computational methods to design de novo protein therapeutics, today announced three presentations at the upcoming American Association for Cancer Research (AACR) Annual Meeting taking place April 8-13, 2022 in New Orleans, Louisiana.

mick

03/12/22 2:41 PM

Post #99

Neoleukin Therapeuti (NLTX)
2.13 ? -0.23 (-9.75%)
Volume: 143,302 @03/11/22 5:50:15 PM EST
Bid Ask Day's Range
2.0 2.14 2.12 - 2.43
NLTX Detailed Quote

mick

02/06/22 4:48 PM

Post #98

Neoleukin Therapeuti (NLTX)
3.28 ? 0.11 (3.47%)
Volume: 230,741 @02/04/22 4:00:57 PM EST
Bid Ask Day's Range
2.68 3.29 3.1 - 3.32
NLTX Detailed Quote

mick

01/04/22 9:30 PM

Post #97

Re: #96: @mick - thank you good repore' $nltx

Neoleukin Therapeuti (NLTX)
4.85 ? -0.38 (-7.27%)
Volume: 216,000 @01/04/22 7:38:36 PM EST
Bid Ask Day's Range
4.0 4.85 4.81 - 5.35
NLTX Detailed Quote

mick

01/04/22 9:30 PM

Post #96

Re: #95: @Phosphene - https://www.geekwire.com/2021/biosensor-startup-monod-lands-6m-and-spins-out-of-univ-of-washingtons-

thank you good repore' $nltx

Phosphene

01/04/22 9:03 PM

Post #95

Re: #94: @mick - https://www.otcmarkets.com/stock/NLTX

https://www.geekwire.com/2021/biosensor-startup-monod-lands-6m-and-spins-out-of-univ-of-washingtons-institute-for-protein-design/

NLTX Co-founder and Head of research recently founded Monod Bio.

December 23, 2021.

mick

01/02/22 5:05 PM

Post #94

https://www.otcmarkets.com/stock/NLTX

mick

12/11/21 5:01 PM

Post #93

https://www.otcmarkets.com/stock/NLTX

mick

11/06/21 12:25 PM

Post #92

Neoleukin Therapeuti (NLTX)
7.69 ? 0.25 (3.36%)
Volume: 172,375 @11/05/21 5:30:12 PM EDT
Bid Ask Day's Range
7.75 8.41 7.25 - 7.9
NLTX Detailed Quote

mick

10/08/21 11:06 AM

Post #91

Neoleukin Therapeuti (NLTX)
6.63 ? -0.07 (-1.04%)
Volume: 3,590 @10/08/21 10:49:01 AM EDT
Bid Ask Day's Range
6.6 6.65 6.61 - 6.74
NLTX Detailed Quote

mick

09/22/21 7:28 PM

Post #90

Re: #89: @mick - Neoleukin Therapeuti (NLTX)

Neoleukin Therapeuti (NLTX)
7.53 ? 0.0 (0.00%)
Volume: 67,454 @09/22/21 4:02:00 PM EDT
Bid Ask Day's Range
7.0 8.4 7.44 - 7.84
NLTX Detailed Quote

mick

08/14/21 12:28 PM

Post #89

Re: #88: @mick - Neoleukin Therapeuti (NLTX)

Neoleukin Therapeuti (NLTX)
6.81 ? -0.18 (-2.58%)
Volume: 114,939 @08/13/21 4:00:54 PM EDT
Bid Ask Day's Range
6.5 8.0 6.75 - 7.15
NLTX Detailed Quote

mick

07/10/21 11:31 PM

Post #88

Neoleukin Therapeuti (NLTX)
9.21 ? 0.32 (3.60%)
Volume: 54,372 @07/09/21 4:00:59 PM EDT
Bid Ask Day's Range
8.19 10.0 8.84 - 9.25
NLTX Detailed Quote

mick

07/08/21 2:08 PM

Post #87

Neoleukin Therapeuti (NLTX)
8.89 ? -0.17 (-1.88%)
Volume: 107,040 @07/08/21 1:52:12 PM EDT
Bid Ask Day's Range
8.87 8.9 8.7 - 8.99
NLTX Detailed Quote

mick

05/26/21 11:43 AM

Post #86

Neoleukin Therapeuti (NLTX)
9.9481 ? 0.0781 (0.79%)
Volume: 74,185 @05/26/21 11:28:02 AM EDT
Bid Ask Day's Range
9.9 9.98 9.83 - 10.21
NLTX Detailed Quote

mick

05/02/21 6:12 PM

Post #85

mick

05/02/21 6:12 PM

Post #84

mick

04/18/21 12:33 PM

Post #83

Re: #81: @mick - Neoleukin Therapeuti (NLTX)

Neoleukin Therapeuti (NLTX)
11.96 ? -0.24 (-1.97%)
Volume: 121,326 @04/16/21 5:03:06 PM EDT
Bid Ask Day's Range
11.2 15.0 11.77 - 12.345
NLTX Detailed Quote

mick

02/20/21 7:13 PM

Post #81

Re: #75: @mick - IT IS TOO OLD TO GET IT

Neoleukin Therapeuti (NLTX)
13.2 ? 0.41 (3.21%)
Volume: 158,178 @02/19/21 4:30:31 PM EST
Bid Ask Day's Range
11.11 14.05 12.83 - 13.5399
NLTX Detailed Quote

mick

01/31/21 8:24 PM

Post #80

Re: #79: @mick - me again o.k.

https://otcbb.swingtradebot.com/equities/NLTX

N.Y. , NASDAQ
https://swingtradebot.com/equities/NLTX

mick

01/14/21 7:07 PM

Post #79

Re: #78: @Schrogtergracht - Well, since you're asking... erm... a few thousand

me again o.k.

Schrogtergracht Free

01/14/21 7:00 PM

Post #78

Re: #77: @mick - thank you, any other business ?????

Well, since you're asking... erm... a few thousand points of the Dow, S&P and Nasdaq, maybe, if it isn't too much trouble? THX!

P.S. After the weekend is ok too, in case you're busy. Fridays and stuff.

mick

01/14/21 6:56 PM

Post #77

Re: #76: @Schrogtergracht - Thanks for trying, mick. P.S. The all

thank you, any other business ?????

Schrogtergracht Free

01/14/21 6:54 PM

Post #76

Re: #75: @mick - IT IS TOO OLD TO GET IT

Thanks for trying, mick. P.S. The all caps had me laughing out loud. Cheers.
(This one is better of in the bin too as it was just to let you know no hard feelings here.)

Older

Neoleukin Therapeutics Inc (NLTX)

Followers	6	Posters	9
Posts (Today)	0	Posts (Total)	126
Created	11/10/19	Type	Free
Moderators

NEOLEUKIN THERAPEUTICS, INC.

360-1616 Eastlake Avenue East

Seattle, WA 98102

(206) 732-2133

https://www.neoleukin.com/
https://www.neoleukin.com/science/
https://www.neoleukin.com/careers/#overview
https://www.neoleukin.com/programs/
https://www.neoleukin.com/news/
http://investor.neoleukin.com/

Principal Scientist, Protein Expression and Optimization in Mammalian Systems

DESCRIPTION

Neoleukin Therapeutics is seeking an exceptional Principal Scientist to lead its efforts in the field of Mammalian Protein expression. The selected candidate will participate in research programs targeting the expression, characterization, and optimization of de novo designed protein therapeutics. The scope of the research will include (but is not limited to) production of complex recombinant proteins and biochemical, biophysical, and thermodynamic characterization. Examples of targets are cytokines, cell-signaling molecules, and soluble forms of membrane cytokine receptors.

The candidate must have at least five years of industry experience in expression, purification, characterization and optimization of recombinant proteins in mammalian systems, including the expression of human antibodies, cytokines, and cytokine receptors.

The appointed scientist will be responsible for designing and managing research programs in collaboration with senior management, as well as to translate our high-level strategic vision into a scientific reality. As an early-stage biotech company, Neoleukin thrives on developing an inspiring work environment that foremost embraces a collaborative team-based approach.

PRIMARY RESPONSIBILITIES

Application of existing biochemical, biophysical and thermodynamic tools for mammalian protein expression
Purification of recombinant proteins using a variety of systems (ion exchange, size exclusion, affinity chromatography)
Characterization of proteins using various methods, such as SDS-PAGE/CE-SDS, SEC-MALS, MS, and endotoxin testing
Troubleshoot and optimize assays through data interpretation, identification of novel or alternate procedures and techniques
Preparation of data summaries, reports, manuscripts, and presentations of research results
Perform experiments with strong attention to detail and excellent documentation
Determination and implementation of research team goals
Building a collaborative network within Neoleukin Therapeutics and with its external research partner
Lead a team of researchers and regularly interfacing with senior management

QUALIFICATIONS

Expertise in the fields of Biochemistry, Chemistry, Molecular or Cell Biology, or related fields in Life Sciences. PhD is highly desired
Substantial proven experience in generation and characterization of recombinant proteins in heterologous systems is required,
including Mammalian systems. Including: Protein Expression and Purification, Biophysics, Protein Structure determination,
Protein Biochemistry, and/or protein engineering Experience in protein analytical techniques, including electrophoresis, Western Blot, ELISAs,
Endotoxin assays, HPLC, FPLC, UV-Vis Spectrophotometry, Calorimetry (ITC/DSC), Fluorescence and Circular Dichroism Spectroscopy,
Surface Plasmon Resonance (SPR) and Mass Spectrometry Proven exceptional record of research, including peer-reviewed publications in international journals
Excellent written and oral communication and presentation skills
Ability to work in a team environment encompassing multiple disciplines with excellent interpersonal and management skills.
A strong desire to work in a highly dynamic environment is essential
Ability to work independently, multi-task and meet deadlines in a fast-paced environment
Committed to the values of integrity, scientific rigor, and transparency

APPLICATIONS CAN BE SUBMITTED TO CAREERS@NEOLEUKIN.COM

Neoleukin Therapeutics is proud to be an equal opportunity employer.
All applicants will be considered for employment without attention to race, color, religion, sex, sexual orientation, gender identity, national origin,
veteran or disability status, or age, and Neoleukin will not tolerate discrimination or harassment based on any of the above characteristics.

LTX SECURITY DETAILS

Share Structure

Market Cap

498,851,080

05/14/2020

Authorized Shares

Not Available

Outstanding Shares

38,373,160 03/12/2020

https://www.otcmarkets.com/stock/NLTX/disclosure

https://www.otcmarkets.com/stock/NLTX/news

https://www.otcmarkets.com/stock/NLTX/security

https://www.otcmarkets.com/stock/NLTX/profile

https://www.otcmarkets.com/stock/NLTX/quote

https://www.otcmarkets.com/stock/NLTX/overview

*DISCLAIMER *The Board Monitor and The Board Assistants herewith, are not licensed brokers and assume NO responsibility for the actions, investment decisions, and or messages posted on this forum.
• We do NOT recommend that anyone buy or sell any securities posted herewith. Any trade entered into risks the possibility of losing the funds invested.
• There are no guarantees when buying or selling any security.